pembrolizumab
merck,cleveland clinic
[]
 terrific meeting with #ascogi23 ! reminiscing on the fun times in cleveland &amp; writing the editorial the fda approval of pembrolizumab for adult &amp; pediatric patients with tumor mutational burden (tmb) 10 
Oncologist | Associate Prof | Executive Director-Research, MD Anderson Cancer Network | Medical Director, Clinical Center for Targeted Therapy. Tweets = my own.